Tay-Sachs Disease Treatment Market Analysis

  • Report ID: 3092
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Tay-Sachs Disease Treatment Market Analysis

The tay-sachs disease treatment market is segmented by stage into infantile, juvenile, and late-onset, out of which, the infantile segment is anticipated to gain the largest revenue in the market during the forecast period, as the symptoms are very severe in infantile Tay-Sachs disease, and require immediate and constant treatment. The symptoms appear at 6-months of age, and include vision loss, movement loss, patches inside eyes, and respiratory issues. On the basis of end-user, the market is segmented into hospitals, homecare, specialty clinics, and others, out of which, the specialty clinics segment is projected to witness major growth during the forecast period, owing to the symptom specific, and targeted treatment provided in such clinics.

Our in-depth analysis of the global market includes the following segments:

           Stage

  • Infantile
  • Juvenile
  • Late- Onset

             Treatment Type

  • Physical Therapy
  • Chest Physiotherapy
  • Respiratory Care
  • Antipsychotic Medications
  • Others

 

 

           End-User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3092
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of tay-sachs disease treatment is estimated at USD 2.39 billion.

Tay-Sachs Disease Treatment Market size was over USD 2.29 billion in 2023 and is anticipated to reach USD 4.71 billion by 2036, witnessing around 5.7% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of the genetic disease in specific communities, and growing R&D investment for medical research will impel the market growth.

North America is likely to hold largest revenue share by 2036, on the back of growing cases of Tay-Sachs disease in the region.

The major players in the market are Sio Gene Therapies Ltd, Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Amgen Inc. and others who manufacture drugs to treat the symptoms of Tay-Sachs disease.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample